Kidney function in newly diagnosed myeloma patients: factors associated with kidney impairment and recovery
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Kidney function in newly diagnosed myeloma patients: factors associated with kidney impairment and recovery ; volume:25 ; number:1 ; day:11 ; month:10 ; year:2024 ; pages:1-11 ; date:12.2024
BMC nephrology ; 25, Heft 1 (11.10.2024), 1-11, 12.2024
- Creator
-
Cesar, Bruno Nogueira
Braga, Walter Moises Tobias
Hamerschlak, Nelson
Junior, Marcelino de Souza Durão
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12882-024-03717-5
- URN
-
urn:nbn:de:101:1-2412272126166.194167839790
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:39 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cesar, Bruno Nogueira
- Braga, Walter Moises Tobias
- Hamerschlak, Nelson
- Junior, Marcelino de Souza Durão
- SpringerLink (Online service)
Other Objects (12)
Clinical comparisons between previously diagnosed SLE and newly diagnosed SLE by kidney biopsy
Antenatally diagnosed kidney tumor: Answers
Chronic Kidney Disease and Cognitive Impairment: The Kidney-Brain Axis
Muscle and fat composition in patients with newly diagnosed multiple myeloma
European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma
Maintenance Strategies Post-Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
Changes in RDW according to prognostic predictors in newly diagnosed multiple myeloma
Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myeloma
Mutational screening of newly diagnosed multiple myeloma patients by deep targeted sequencing
Efficacy and tolerability of bortezomib and dexamethasone in newly diagnosed multiple myeloma
Treatment Satisfaction and Burden of Illness in Patients with Newly Diagnosed Multiple Myeloma
The Cost Impact of Lenalidomide for Newly Diagnosed Multiple Myeloma in the EU5
Clinical comparisons between previously diagnosed SLE and newly diagnosed SLE by kidney biopsy
Antenatally diagnosed kidney tumor: Answers
Chronic Kidney Disease and Cognitive Impairment: The Kidney-Brain Axis
Muscle and fat composition in patients with newly diagnosed multiple myeloma
European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma
Maintenance Strategies Post-Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
Changes in RDW according to prognostic predictors in newly diagnosed multiple myeloma
Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myeloma
Mutational screening of newly diagnosed multiple myeloma patients by deep targeted sequencing
Efficacy and tolerability of bortezomib and dexamethasone in newly diagnosed multiple myeloma
Treatment Satisfaction and Burden of Illness in Patients with Newly Diagnosed Multiple Myeloma
The Cost Impact of Lenalidomide for Newly Diagnosed Multiple Myeloma in the EU5
Clinical comparisons between previously diagnosed SLE and newly diagnosed SLE by kidney biopsy
Antenatally diagnosed kidney tumor: Answers
Chronic Kidney Disease and Cognitive Impairment: The Kidney-Brain Axis
Muscle and fat composition in patients with newly diagnosed multiple myeloma
European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma
Maintenance Strategies Post-Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
Changes in RDW according to prognostic predictors in newly diagnosed multiple myeloma
Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myeloma
Mutational screening of newly diagnosed multiple myeloma patients by deep targeted sequencing
Efficacy and tolerability of bortezomib and dexamethasone in newly diagnosed multiple myeloma
Treatment Satisfaction and Burden of Illness in Patients with Newly Diagnosed Multiple Myeloma